Clarient to Present at Upcoming Healthcare Investor Conferences in New York City
|
| Posted
:
Mon, 09 Nov 2009 11:01:38 GMT |
| Author
:
Clarient, Inc. |
| Category
:
Press Release |
| News Alerts by
Email ( click
here ) |
|
|
|
|
ALISO VIEJO, Calif., Nov. 9 /PRNewswire-FirstCall/ -- Clarient, Inc. (Nasdaq: CLRT), a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that it is scheduled to make presentations at two upcoming investor conferences in New York City.
The first presentation will be made at the Lazard Capital Markets Sixth Annual Healthcare Conference at 1:40 pm EST on Tuesday, November 17. The conference will be held at the St. Regis Hotel November 17-18.
The second presentation will be made at the 21st Annual Piper Jaffray Health Care Conference at 10:30 am EST on Wednesday, December 2. The conference will be held at the New York Palace Hotel December 1-2.
Live webcasts of the Company's presentations at the conferences will be available via a link provided at http://www.clarientinc.com/investor. Archived replays of the presentations will also be available shortly after the presentation time for a period of at least 60 days.
About Clarient
Clarient combines innovative diagnostic technologies with world-class pathology expertise to assess and characterize cancer. Clarient's mission is to become the leader in cancer diagnostics by collaborating with the healthcare community to translate cancer research and development into better patient care. Clarient's principal customers include pathologists, oncologists, hospitals and biopharmaceutical companies. The rise of individualized medicine has created the need for a centralized resource which provides leading oncology diagnostic technologies, such as flow cytometry and molecular testing. Clarient is that resource, having created a state-of-the-art commercial cancer laboratory, which provides the most advanced oncology testing and diagnostic services available. Resulting diagnostic reports and analyses are made available to customers through Clarient's Internet-based portal, PATHSiTE(TM). Clarient also plans to develop and market new, proprietary "companion" diagnostic markers for therapeutics in breast, prostate, lung and colon cancers, and leukemia/lymphoma. www.clarientinc.com
Investor Contact:
Matt Clawson
Allen & Caron Inc
(949) 474-4300
matt@allencaron.com
SOURCE Clarient, Inc.
|
Copyright © 2008
PR Newswire. All rights reserved.
|
|
|
|
|
Related
News
Kabira(TM) Technologies to Highlight Its Communications Product Suite
SAN MATEO, CA -- 11/24/09 --
Kabira Technologies, Inc., a leading
telecommunications software provider and associate member of the TM Forum,
today announced that it will exhibit at TM Forum Management World Americas,
at Rosen Shingle Creek in Orla..
Certain ProShares ETF Funds Submission Deadlines for Investors Announced by Bernstein Liebhard LLP
NEW YORK, NY -- 11/24/09 --
Bernstein Liebhard LLP has filed a case
against ProShares Trust ("ProShares") concerning ProShares' DXD (NYSE: DXD)
fund. This complaint alleges that ProShares, as well as others, violated
the Securities Act of 1933 by ..
The Scotts Miracle-Gro Company Annual Report 10-K Filed
MARYSVILLE, Ohio, Nov. 24 -- The Scotts Miracle-Gro Company (NYSE: SMG), the world's leading marketer of branded consumer lawn and garden products, announced today that its Annual Report on Form 10-K for the fiscal year ending September 30, 2009 is on file with th...
Colorado BioScience Association Moves Offices with Two Other Associations to Columbine Place at 216 16th Street, Suite 850, Denver
DENVER -
The Colorado BioScience Association (CBSA) along with the Colorado
Association of Manufacturing and Technology (CAMT) and the Colorado
Software and Internet Association (CSIA) have moved together to a new
office located in Downtown Denver. The announcement is made by John
Col
NuMobile, Inc. Announces 3rd Quarter Update Webcast in Conjunction With Current Financial Report Reflecting Recent Acquisition and New Business Plan
CARY, NC -- 11/24/09 --
NuMobile, Inc. (OTCBB: NUBL), a fully-reporting
over-the-counter bulletin board listed company, today announced the release
of an on-demand Webcast to review a third quarter update. The Company filed
its 3rd quarter financia..
Dyyno Appoints Ken Hausman as Vice President of Corporate Development
PALO ALTO, CA -- 11/24/09 --
Dyyno, the breakthrough online video
distribution platform, today announced the appointment of Ken Hausman to
the position of vice president of corporate development. Hausman has more
than 25 years of senior management ..
Cohen & Steers Funds Announce Results of Special Stockholder Meetings
NEW YORK, Nov. 24 -- Cohen & Steers Advantage Income Realty Fund, Inc. (NYSE: RLF) and Cohen & Steers Premium Income Realty Fund, Inc. (NYSE: RPF) announced today at the special joint meetings of stockholders that each fund has approved merging with an...
|
|
|
|
|
|
|
|
|
